Biotech News
GENFIT Announces 2026 Financial Calendar
ir.genfit.com2026-05-06 15:04 EST
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 7, 2026 - GENFIT (Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its provisional financial